Laboratoires Thea SA - Company Profile
Powered by 
All the data and insights you need on Laboratoires Thea SA in one report.
$295
- Save hours of research time and resources with
our up-to-date Laboratoires Thea SA Strategy Report
- Understand Laboratoires Thea SA position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Laboratoires Thea SA Catalyst Calendar
Proactively evaluate Laboratoires Thea SA’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Laboratoires Thea SA Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 01 Apr 2021 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 30 Dec 2020 | Phase II Trial Completion | Laboratoires Thea SA; SynsLaser Kirurgi AS; The Research Council of Norway | - | Cacicol20 | Central Nervous System; Ophthalmology | Post-Operative Pain; Unspecified Ophthalmological Disorders | Clinical Trial Registry |
| 01 Apr 2020 | Phase III Trial Completion | Iris Pharma; Laboratoires Thea SA; OCT Clinical Trials | - | bimatoprost | Ophthalmology | Glaucoma; Ocular Hypertension; Open-Angle Glaucoma | Clinical Trial Registry |
| 04 Mar 2020 | Phase II Trial Completion | 3T Research Kft; Laboratoires Thea SA | - | (bimatoprost + timolol) | Ophthalmology | Glaucoma; Ocular Hypertension; Open-Angle Glaucoma | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer